杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/08/13 | 1,734 | 1,740 | 1,716 | 1,737 | -17 | -1% | 156,600 |
2019/08/09 | 1,751 | 1,768 | 1,749 | 1,754 | +17 | +1% | 126,100 |
2019/08/08 | 1,722 | 1,746 | 1,702 | 1,737 | +15 | +0.9% | 195,300 |
2019/08/07 | 1,724 | 1,732 | 1,711 | 1,722 | -11 | -0.6% | 147,900 |
2019/08/06 | 1,703 | 1,737 | 1,688 | 1,733 | -20 | -1.1% | 229,700 |
2019/08/05 | 1,782 | 1,782 | 1,731 | 1,753 | -48 | -2.7% | 201,500 |
2019/08/02 | 1,800 | 1,819 | 1,786 | 1,801 | -13 | -0.7% | 369,700 |
2019/08/01 | 1,831 | 1,836 | 1,804 | 1,814 | -23 | -1.3% | 214,200 |
2019/07/31 | 1,800 | 1,862 | 1,789 | 1,837 | +26 | +1.4% | 595,700 |
2019/07/30 | 1,789 | 1,811 | 1,785 | 1,811 | +30 | +1.7% | 201,800 |
2019/07/29 | 1,806 | 1,810 | 1,776 | 1,781 | -19 | -1.1% | 177,500 |
2019/07/26 | 1,783 | 1,801 | 1,770 | 1,800 | -4 | -0.2% | 255,900 |
2019/07/25 | 1,805 | 1,805 | 1,788 | 1,804 | -2 | -0.1% | 202,200 |
2019/07/24 | 1,811 | 1,811 | 1,787 | 1,806 | -23 | -1.3% | 319,800 |
2019/07/23 | 1,805 | 1,838 | 1,794 | 1,829 | +24 | +1.3% | 243,900 |
2019/07/22 | 1,806 | 1,820 | 1,799 | 1,805 | -18 | -1% | 216,700 |
2019/07/19 | 1,796 | 1,831 | 1,789 | 1,823 | +23 | +1.3% | 334,900 |
2019/07/18 | 1,842 | 1,849 | 1,796 | 1,800 | -41 | -2.2% | 271,600 |
2019/07/17 | 1,831 | 1,846 | 1,822 | 1,841 | +5 | +0.3% | 200,400 |
2019/07/16 | 1,860 | 1,866 | 1,828 | 1,836 | -32 | -1.7% | 240,100 |
2019/07/12 | 1,889 | 1,889 | 1,855 | 1,868 | -21 | -1.1% | 156,600 |
2019/07/11 | 1,866 | 1,894 | 1,856 | 1,889 | +12 | +0.6% | 141,800 |
2019/07/10 | 1,859 | 1,882 | 1,846 | 1,877 | -10 | -0.5% | 235,800 |
2019/07/09 | 1,926 | 1,926 | 1,877 | 1,887 | -23 | -1.2% | 241,300 |
2019/07/08 | 1,938 | 1,938 | 1,906 | 1,910 | -61 | -3.1% | 233,500 |
2019/07/05 | 1,998 | 1,998 | 1,959 | 1,971 | -2 | -0.1% | 205,600 |
2019/07/04 | 1,980 | 2,006 | 1,973 | 1,973 | +4 | +0.2% | 110,100 |
2019/07/03 | 1,991 | 1,999 | 1,967 | 1,969 | -21 | -1.1% | 172,600 |
2019/07/02 | 1,966 | 1,997 | 1,960 | 1,990 | +19 | +1% | 129,000 |
2019/07/01 | 1,934 | 1,974 | 1,928 | 1,971 | +63 | +3.3% | 232,900 |
2019/06/28 | 1,889 | 1,908 | 1,879 | 1,908 | +41 | +2.2% | 303,900 |
2019/06/27 | 1,859 | 1,874 | 1,855 | 1,867 | -1 | -0.1% | 161,200 |
2019/06/26 | 1,863 | 1,879 | 1,846 | 1,868 | +8 | +0.4% | 226,400 |
2019/06/25 | 1,899 | 1,904 | 1,851 | 1,860 | -19 | -1% | 278,400 |
2019/06/24 | 1,865 | 1,884 | 1,865 | 1,879 | +4 | +0.2% | 102,800 |
2019/06/21 | 1,908 | 1,908 | 1,871 | 1,875 | -39 | -2% | 249,000 |
2019/06/20 | 1,925 | 1,943 | 1,914 | 1,914 | +9 | +0.5% | 169,200 |
2019/06/19 | 1,884 | 1,908 | 1,875 | 1,905 | +46 | +2.5% | 165,600 |
2019/06/18 | 1,871 | 1,888 | 1,857 | 1,859 | -1 | -0.1% | 100,300 |
2019/06/17 | 1,880 | 1,881 | 1,860 | 1,860 | -29 | -1.5% | 90,200 |
2019/06/14 | 1,903 | 1,903 | 1,881 | 1,889 | -19 | -1% | 200,300 |
2019/06/13 | 1,915 | 1,917 | 1,894 | 1,908 | +1 | +0.1% | 182,600 |
2019/06/12 | 1,917 | 1,928 | 1,907 | 1,907 | -8 | -0.4% | 127,800 |
2019/06/11 | 1,953 | 1,953 | 1,913 | 1,915 | -53 | -2.7% | 271,100 |
2019/06/10 | 1,955 | 1,981 | 1,955 | 1,968 | +24 | +1.2% | 105,500 |
2019/06/07 | 1,955 | 1,971 | 1,935 | 1,944 | +18 | +0.9% | 166,600 |
2019/06/06 | 1,912 | 1,944 | 1,902 | 1,926 | -7 | -0.4% | 196,200 |
2019/06/05 | 1,897 | 1,943 | 1,886 | 1,933 | +67 | +3.6% | 203,700 |
2019/06/04 | 1,886 | 1,894 | 1,858 | 1,866 | +9 | +0.5% | 186,200 |
2019/06/03 | 1,872 | 1,872 | 1,849 | 1,857 | -40 | -2.1% | 144,700 |
1401~
1450
件表示中 / 3695件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 148,800円 | +8.8% | +99.9% | 3.49% | 9.50倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ゼリア新薬 | 217,600円 | +3.1% | -6.5% | 2.21% | 10.10倍 | 1.07倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
持田薬 | 309,500円 | +3.0% | +27.5% | 2.58% | 19.59倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 223,000円 | +0.4% | -8.4% | 2.38% | 28.63倍 | 1.60倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 87,600円 | +20.3% | - | 0.00% | 154.50倍 | 1.15倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム